Improving diagnosis of tumor-induced osteomalacia with gallium-68 DOTATATE PET/CT

R.J.D. Clifton-Bligh, M.S. Hofman, E. Duncan, I. Sim, D. Darnell, A. Clarkson, T. Wong, John Walsh, A.J. Gill, P.R. Ebeling, R.J. Hicks

    Research output: Contribution to journalArticle

    58 Citations (Scopus)

    Abstract

    Context: Tumor-induced osteomalacia (TIO) is a rarely diagnosed disorder presenting with bone pain, fractures, muscle weakness, and moderate-to-severe hypophosphatemia resulting from fibroblast growth factor 23-mediated renal phosphate wasting. Tumors secreting fibroblast growth factor 23 are often small and difficult to find with conventional imaging. Objective: We studied the utility of 68Ga-DOTA-octreotate (DOTATATE) somatostatin receptor positron emission tomography (PET)/computed tomography (CT) imaging in the diagnosis of TIO. Design and Setting: A multicenter case series was conducted at tertiary referral hospitals. Patients and Methods: Six patients with TIO diagnosed between 2003 and 2012 in Australia were referred for DOTATATE PET imaging. We reviewed the clinical history, biochemistry, imaging characteristics, histopathology, and clinical outcome of each patient. Results: Each case demonstrated delayed diagnosis despite severe symptoms. DOTATATE PET/CT imaging demonstrated high uptake and localized the tumor with confidence in each case. After surgical excision, there was resolution of clinical symptoms and serum phosphate, except in one patient who demonstrated residual disease on PET/CT. All tumors demonstrated high somatostatin receptor subtype 2 cell surface receptor expression using immunohistochemistry. Conclusions: In patients with TIO, DOTATATE PET/CT can successfully localize phosphaturic mesenchymal tumors and may be a practical first step in functional imaging for this disorder. Serum phosphate should be measured routinely in patients with unexplained muscle weakness, bone pain, or stress fractures to allow earlier diagnosis of TIO. Copyright © 2013 by The Endocrine Society.
    Original languageEnglish
    Pages (from-to)687-694
    JournalJournal of Clinical Endocrinology and Metabolism
    Volume98
    Issue number2
    DOIs
    Publication statusPublished - 2013

      Fingerprint

    Cite this

    Clifton-Bligh, R. J. D., Hofman, M. S., Duncan, E., Sim, I., Darnell, D., Clarkson, A., ... Hicks, R. J. (2013). Improving diagnosis of tumor-induced osteomalacia with gallium-68 DOTATATE PET/CT. Journal of Clinical Endocrinology and Metabolism, 98(2), 687-694. https://doi.org/10.1210/jc.2012-3642